HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jeonghee Cho Selected Research

AT 7867

3/2021Dual Inhibition of AKT and MEK Pathways Potentiates the Anti-Cancer Effect of Gefitinib in Triple-Negative Breast Cancer Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jeonghee Cho Research Topics

Disease

16Neoplasms (Cancer)
03/2021 - 05/2005
8Adenocarcinoma of Lung
06/2014 - 12/2007
6Lung Neoplasms (Lung Cancer)
07/2022 - 06/2011
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2022 - 05/2013
5Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 05/2013
3Stomach Neoplasms (Stomach Cancer)
11/2017 - 05/2013
2Triple Negative Breast Neoplasms
06/2021 - 03/2021
2Adenocarcinoma
01/2020 - 06/2014
2Colonic Neoplasms (Colon Cancer)
01/2020 - 06/2014
2Carcinogenesis
12/2019 - 11/2017
2Neoplasm Metastasis (Metastasis)
01/2017 - 12/2015
1Leukemia
03/2021
1Sarcoma (Soft Tissue Sarcoma)
03/2021
1Thymoma (Thymic Carcinoma)
03/2021
1Hypoxia (Hypoxemia)
02/2016
1Neuroendocrine Tumors (Neuroendocrine Tumor)
12/2015
1Head and Neck Neoplasms (Head and Neck Cancer)
06/2014
1Breast Neoplasms (Breast Cancer)
05/2013
1Glioblastoma (Glioblastoma Multiforme)
12/2011
1Carcinoma (Carcinomatosis)
01/2011
1Inflammation (Inflammations)
02/2005
1Septic Shock (Toxic Shock Syndrome)
09/2002

Drug/Important Bio-Agent (IBA)

10ErbB Receptors (EGF Receptor)IBA
06/2021 - 12/2011
7Phosphotransferases (Kinase)IBA
04/2015 - 05/2005
5Cetuximab (Erbitux)FDA Link
01/2020 - 11/2013
3Monoclonal AntibodiesIBA
01/2020 - 11/2013
3Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2018 - 06/2011
3DNA (Deoxyribonucleic Acid)IBA
01/2013 - 12/2007
3Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
05/2005 - 09/2002
2Gefitinib (Iressa)FDA Link
03/2021 - 04/2015
2Panitumumab (Vectibix)FDA Link
01/2020 - 12/2019
2Tyrosine (L-Tyrosine)FDA Link
01/2018 - 06/2011
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
05/2013 - 09/2012
2Transcription Factors (Transcription Factor)IBA
01/2013 - 12/2007
2Death Domain ReceptorsIBA
05/2005 - 02/2005
1Tyrosine Kinase InhibitorsIBA
07/2022
1Therapeutic UsesIBA
06/2021
1AT 7867IBA
03/2021
1Drug CombinationsIBA
03/2021
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
03/2021
1Protein Kinase InhibitorsIBA
03/2021
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
03/2021
1LigandsIBA
01/2020
1c-Mer Tyrosine KinaseIBA
11/2017
1Messenger RNA (mRNA)IBA
01/2017
1Calcibiotic Root Canal SealerIBA
01/2017
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
03/2016
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2016
1MicroRNAs (MicroRNA)IBA
12/2015
1AfatinibIBA
04/2015
1dacomitinibIBA
04/2015
1pazopanibFDA Link
11/2014
1AntibodiesIBA
06/2014
1tyrosine receptor (receptor, tyrosine)IBA
05/2013
1Epidermal Growth Factor (EGF)IBA
05/2013
1Anaplastic Lymphoma KinaseIBA
05/2013
1CrizotinibIBA
05/2013
1Proto-Oncogene Proteins c-metIBA
05/2013
1ChromatinIBA
01/2013
1NucleotidesIBA
09/2012
1Biological ProductsIBA
09/2012
1Discoidin Domain Receptor 2IBA
06/2011
1Dasatinib (BMS 354825)FDA Link
06/2011
1Platelet-Derived Growth Factor alpha ReceptorIBA
11/2009
1Toll-Like Receptors (Toll-Like Receptor)IBA
05/2005
1LipopolysaccharidesIBA
05/2005
1GalactosamineIBA
09/2002
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2002

Therapy/Procedure

9Therapeutics
07/2022 - 12/2007
1Drug Therapy (Chemotherapy)
05/2013